Targiniq ER Interactions
There are 619 drugs known to interact with Targiniq ER (naloxone/oxycodone), along with 20 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 215 are major, 400 are moderate, and 4 are minor.
- View all 619 medications that may interact with Targiniq ER
- View Targiniq ER alcohol/food interactions (1)
- View Targiniq ER disease interactions (20)
Most frequently checked interactions
View interaction reports for Targiniq ER (naloxone / oxycodone) and the medicines listed below.
- amitriptyline
- aspirin
- atorvastatin
- Celebrex (celecoxib)
- codeine
- diazepam
- duloxetine
- Endep (amitriptyline)
- furosemide
- gabapentin
- Lyrica (pregabalin)
- meloxicam
- metformin
- metoclopramide
- mirtazapine
- Nexium (esomeprazole)
- ondansetron
- oxycodone
- Panadol Osteo (acetaminophen)
- pantoprazole
- Paracetamol (acetaminophen)
- perindopril
- pregabalin
- quetiapine
- Seroquel (quetiapine)
- tapentadol
- temazepam
- tramadol
- Valium (diazepam)
- Vitamin D3 (cholecalciferol)
Targiniq ER alcohol/food interactions
There is 1 alcohol/food interaction with Targiniq ER (naloxone / oxycodone).
Targiniq ER disease interactions
There are 20 disease interactions with Targiniq ER (naloxone / oxycodone) which include:
- CV disorders
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- liver disease
- renal
- septic shock
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
More about Targiniq ER (naloxone / oxycodone)
- Targiniq ER consumer information
- Compare alternatives
- Reviews (2)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: narcotic analgesic combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.